Kirk Ogrosky represents corporations and executives in civil and criminal investigations, False Claims Act litigation, and trial. Having a track record of successful resolutions and an ability to achieve timely results has been the hallmark of his practice. If unable to resolve a matter, he is an experienced trial attorney and litigator having first-chaired numerous high profile cases.

Kirk’s practice focuses on fraud and abuse matters in the healthcare and government contracting sectors. He has taken almost 40 defendants through trial to verdict during the past 20 years, and juries have returned verdicts in his favor on all counts in trials he has first-chaired in the last 10 years. Kirk frequently speaks as a faculty member, panelist and keynote on fraud issues, foreign bribery, and trial. He serves as an Adjunct Professor of Law at Georgetown University where he teaches courses on the use of experts and healthcare fraud.

Prior to joining the firm, Kirk served as the Deputy Chief of the Fraud Section in the Criminal Division of DOJ from 2006 to 2010 and as an Assistant US Attorney in the Southern District of Florida from 1999 to 2004. Based on his government service, he is widely recognized as the key architect behind modern criminal healthcare enforcement programs. While at DOJ, he managed prosecutors handling national FCA parallel proceedings, FCPA investigations, and securities fraud matters. He also served on committees of the joint DOJ-HHS Healthcare Fraud Prevention and Enforcement Action Team (HEAT).


  • Litigated False Claims Act cases involving allegations related to (a) hospital and provider billing of drugs and devices; (b) cost report fraud; (c) improper rebating; and (d) miscoding of patient transfers, among others.
  • Pharmaceutical manufacturers in qui tam cases related to alleged violations of the FDCA and Anti-Kickback Statute violations.
  • Pharmaceutical and device manufacturers and senior executives in FCPA and UK Bribery Act investigations.
  • Physicians and individuals in litigation involving healthcare fraud offenses.
  • Healthcare providers and physicians in government investigations and qui tam cases involving alleged health care fraud, Anti-Kickback Statute, and Stark law violations.


Cooperation or Accountability? Yates Memo Puts Spotlight on Pharmaceutical and Medical Device Executives
Bloomberg BNA's Pharmaceutical Law & Industry Report
Defense Victory In Criminal Healthcare Fraud Trial
Arnold & Porter Advisory
Pharmaceutical and Medical Device Compliance Update: Management of Critical and Emerging Legal Challenges
Arnold & Porter Seminar/Conference
Global Anti-Corruption Insights
FCPA News and Insights
The Stark/False Claims Act Booby Trap

Bloomberg's BNA's Medicare Report



US Attorney General's Award for Distinguished Service, 2008

US Assistant Attorney General's Award for Special Initiative, 2007

HHS OIG's Exceptional Achievement and Prosecutive Leadership Awards, 2010



  • JD, The George Washington University Law School
  • BA, Washington University in St. Louis
  • District of Columbia
  • Kentucky
  • US Court of Appeals for the District of Columbia Circuit
  • US Court of Appeals for the Eleventh Circuit
  • US Court of Appeals for the Fourth Circuit
  • US Court of Appeals for the Sixth Circuit
  • US District Court for the District of Columbia
  • US District Court for the Eastern District of Kentucky
  • US District Court for the Western District of Kentucky
  • Member, BNA Health Care Fraud Report Advisory Board


Email Disclaimer